{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T03:18:09Z","timestamp":1779333489522,"version":"3.51.4"},"reference-count":15,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004484","name":"Tehran University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004484","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","msard-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.msard.2025.106285","type":"journal-article","created":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T11:22:55Z","timestamp":1737544975000},"page":"106285","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Is it time to consider the live attenuated varicella-zoster virus (VZV) vaccination safe in patients with multiple sclerosis treated with natalizumab? An extension study of the first Iranian experience"],"prefix":"10.1016","volume":"95","author":[{"given":"Sepideh","family":"Paybast","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad Ali","family":"Nahayati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sareh","family":"shahmohammadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samira","family":"Navardi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryam","family":"Poursadeghfard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marzieh","family":"Aboutorabi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Houra","family":"Heydari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3224-8807","authenticated-orcid":false,"given":"Mohammad Ali","family":"Sahraian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.msard.2025.106285_bib0001","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.japh.2022.07.009","article-title":"Comparative efficacy and safety of disease-modifying therapies in patients with relapsing multiple sclerosis: a systematic review and network meta-analysis","volume":"63","author":"Chen","year":"2023","journal-title":"J. Am. Pharm. Assoc."},{"key":"10.1016\/j.msard.2025.106285_bib0002","doi-asserted-by":"crossref","first-page":"3338","DOI":"10.1016\/j.vaccine.2021.04.049","article-title":"Safety and efficacy of early vaccination with live attenuated measles vaccine for hematopoietic stem cell transplant recipients and solid organ transplant recipients","volume":"39","author":"Groeneweg","year":"2021","journal-title":"Vaccine"},{"key":"10.1016\/j.msard.2025.106285_bib0003","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000011242","article-title":"Effect of disease-modifying therapy on disability in relapsing-remitting multiple sclerosis over 15 years","volume":"96","author":"Kalincik","year":"2021","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2025.106285_bib0004","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.549842","article-title":"Natalizumab in multiple sclerosis treatment: from biological effects to Immune monitoring","volume":"11","author":"Khoy","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.msard.2025.106285_bib0005","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1177\/13524585231204121","article-title":"Safety of anti-varicella zoster virus vaccination in patients with multiple sclerosis treated with natalizumab: a case series","volume":"29","author":"Lapucci","year":"2023","journal-title":"Mult. Scler. J."},{"key":"10.1016\/j.msard.2025.106285_bib0006","unstructured":"Lopez, A., Harrington, T., Marin, M., 2021. Pinkbook: varicella | CDC [WWW Document]. CDC. URL https:\/\/www.cdc.gov\/vaccines\/pubs\/pinkbook\/varicella.html."},{"key":"10.1016\/j.msard.2025.106285_bib0007","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1177\/13524585231168043","article-title":"ECTRIMS\/EAN consensus on vaccination in people with multiple sclerosis: improving immunization strategies in the era of highly active immunotherapeutic drugs","volume":"29","author":"Otero-Romero","year":"2023","journal-title":"Mult. Scler. J."},{"key":"10.1016\/j.msard.2025.106285_bib0008","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2023.104793","article-title":"Investigation of the safety of live attenuated varicella-zoster virus vaccination in patients with relapse-remitting multiple sclerosis treated with natalizumab: a case series and review of the literature","volume":"77","author":"Paybast","year":"2023","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2025.106285_bib0009","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1212\/CON.0000000000000739","article-title":"Management of multiple sclerosis relapses","volume":"25","author":"Repovic","year":"2019","journal-title":"Contin. Lifelong Learn. Neurol."},{"key":"10.1016\/j.msard.2025.106285_bib0010","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1177\/13524585231204126","article-title":"Rethinking vaccination in multiple sclerosis: the way forward","volume":"29","author":"Reyes","year":"2023","journal-title":"Mult. Scler. J."},{"key":"10.1016\/j.msard.2025.106285_bib0011","doi-asserted-by":"crossref","DOI":"10.1136\/practneurol-2020-002527","article-title":"Protecting people with multiple sclerosis through vaccination","volume":"20","author":"Reyes","year":"2020","journal-title":"Pract. Neurol."},{"key":"10.1016\/j.msard.2025.106285_bib0012","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1177\/1352458520952310","article-title":"Vaccinations in patients with multiple sclerosis: a Delphi consensus statement","volume":"27","author":"Riva","year":"2021","journal-title":"Mult. Scler. J."},{"key":"10.1016\/j.msard.2025.106285_bib0013","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1177\/1352458511421919","article-title":"Immunological and clinical consequences of treating a patient with natalizumab","volume":"18","author":"Schwab","year":"2012","journal-title":"Mult. Scler. J."},{"key":"10.1016\/j.msard.2025.106285_bib0014","article-title":"Vaccination in multiple sclerosis \u2011 challenging practices (Review)","volume":"20","author":"Sirbu","year":"2020","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.msard.2025.106285_bib0015","doi-asserted-by":"crossref","first-page":"39","DOI":"10.2174\/2772432817666220412110720","article-title":"Safety and monitoring of the treatment with disease-modifying therapies (DMTs) for multiple sclerosis (MS)","volume":"18","author":"Stamatellos","year":"2023","journal-title":"Curr. Rev. Clin. Exp. Pharmacol."}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221103482500029X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221103482500029X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T04:48:31Z","timestamp":1741841311000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221103482500029X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":15,"alternative-id":["S221103482500029X"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2025.106285","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Is it time to consider the live attenuated varicella-zoster virus (VZV) vaccination safe in patients with multiple sclerosis treated with natalizumab? An extension study of the first Iranian experience","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2025.106285","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"106285"}}